Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells
Biosensors · 2025
DOI: 10.3390/bios16010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Elodie Barthout und 12 weiteren Autor:innen. Beteiligte Einrichtung: UMR INSERM 1308 CAPTuR, University of Limoges, 87025 Limoges, France. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Extracellular Vesicles, Biosensing Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conseil Régional de Nouvelle-Aquitaine, European Union's Horizon 2020 research and innovation program, European Union’s Horizon 2020 research and innovation program.
Abstract (Originalsprache)
Cancer stem cells (CSCs) remain challenging to isolate and characterize because of their plastic phenotype. To overcome this issue, we used a microfluidic lab-on-a-chip analysis approach based on ultra-high frequency dielectophoresis (UHF-DEP) to measure the dielectrophoretic signature of colorectal cancer cells. We demonstrated that CSCs exhibit a distinct and lower frequency signature than differentiated cancer cells. Extracellular vesicles (EVs) released by tumor cells are implicated in tumor progression and metastasis. As CSC-derived EVs carry a more aggressive cargo, we hypothesized that treating differentiated colorectal cancer cells with these vesicles might affect their phenotype which would be detected by our lab on a chip. Indeed, the dielectrophoretic signature of cells treated with those EVs was altered in comparison to untreated cells, even in cases where no detectable biological changes were observed. Compared to conventional approaches using biomarkers to characterize CSCs, this UHF-DEP lab on a chip is a label-free method providing rapid and relevant results. Such a method could be useful in the clinic for the early detection of CSCs in the tumor mass, as well as for monitoring CSC-derived EVs in the bloodstream in order to study responses to therapy and prevent relapses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UMR INSERM 1308 CAPTuR, University of Limoges, 87025 Limoges, France.
- UMR CNRS 7252 XLIM, University of Limoges, 87060 Limoges, France.
- UMR 5203 INSERM/CNRS, Institute of Functional Genomics, University of Montpellier, 34094 Montpellier, France.
- Department of General, Endocrine and Digestive Surgery, University Hospital of Limoges, 87025 Limoges, France.
ORCID-Profile: Elodie Barthout, Elisa Lambert, Stéphanie Durand, Céline Hervieu, Léa Ikhlef, Sofiane Saada, Arnaud Pothier, Fabrice Lalloué, Muriel Mathonnet, Barbara Bessette
Förderung
- Conseil Régional de Nouvelle-Aquitaine
- European Union's Horizon 2020 research and innovation program
- European Union’s Horizon 2020 research and innovation program
Zitieren
APA
Barthout, E., Lambert, E., Durand, S., Hervieu, C., Ikhlef, L., Saada, S., Manczak, R., Pannequin, J., Pothier, A., Dalmay, C., Lalloué, F., Mathonnet, M., & Bessette, B. (2025). Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells. Biosensors. https://doi.org/10.3390/bios16010002
Vancouver
Barthout E, Lambert E, Durand S, Hervieu C, Ikhlef L, Saada S, et al. Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells. Biosensors. 2025. doi:10.3390/bios16010002
BibTeX
@article{Barthout2025,
author = {Barthout, Elodie and Lambert, Elisa and Durand, Stéphanie and Hervieu, Céline and Ikhlef, Léa and Saada, Sofiane and Manczak, Rémi and Pannequin, Julie and Pothier, Arnaud and Dalmay, Claire and Lalloué, Fabrice and Mathonnet, Muriel and Bessette, Barbara},
title = {Ultra-High-Frequency-Dielectrophoresis Microfluidic Biosensor to Detect the Transformation Potential of Extracellular Vesicles Derived from Cancer Stem Cells},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios16010002}
}
EUVIMED